Yuan, Shiqi
Wu, Wentao
Ma, Wen
Huang, Xiaxuan
Huang, Tao
Peng, MIn
Xu, Anding
Lyu, Jun http://orcid.org/0000-0002-2237-8771
Funding for this research was provided by:
Innovative Research Group Project of the National Natural Science Foundation of China (81971121)
Guangdong Provincial Key Laboratory for Translational Cancer Research of Chinese Medicine, Guangzhou University of Chinese Medicine (Grant No. 2021B1212040007)
Article History
Received: 7 June 2022
Accepted: 1 September 2022
First Online: 9 September 2022
Declarations
:
: The UK Biobank study was approved by the Northwest Multicenter Research Ethics Committee, and all participants agreed to their inclusion. Our study was conducted under a UK Biobank license (Applications ID:76636).
: All the authors agreed to publish this article.
: The authors have no funding and conflicts of interest to disclose.